Cite

HARVARD Citation

    Ambrosini, M. et al. (2022). ALK Inhibitors in Patients With ALK Fusion–Positive GI Cancers: An International Data Set and a Molecular Case Series. JCO precision oncology. p. . [Online]. 
  
Back to record